LASIK surgery, specifically iLASIK surgery, utilizes two lasers to help reshape the eye to reduce dependence on glasses and contact lenses. LASIK surgery was first performed in 1990 and has since grown to become one of the most popular elective procedures performed throughout the world due to its effectiveness, safety and remarkable results to help people reduce dependence on glasses and contacts.
How is iLASIK performed?
iLASIK involves utilizing a laser (iFS Advanced Femtosecond Laser) to create an ultra-precise, thin-flap of corneal tissue. This flap is then folded back to expose the thicker part of the cornea. The wavefront-guided treatment is then applied by the CustomVue laser technology to reshape the eye. This is aided by Iris Registration tracking technology which maintains alignment of the customized shape throughout the treatment. The entire surgery typically lasts between 10-15 minutes, with total laser time usually between 30-45 seconds per eye.
What are the risks of iLASIK surgery?
One of the primary benefits of iLASIK is its increased safety profile compared to older versions of LASIK. Flap complication, infection and corneal weakness following the treatment are the most sight-threatening risks. The probability for any of these issues with iLASIK is extremely rare. More common initial side effects that typically fade with time are dry eye and changes in night vision. Extensive research by the military determined that iLASIK offered such excellent results for all types of vision that military pilots and NASA astronauts can now have LASIK, but only with iLASIK technologies.
What are the results of iLASIK?
With the use of iLASIK technologies, 95% of patients achieve 20/20 or better vision with the initial treatment. 100% have achieved 20/40 or better vision (legal driving vision without glasses or contacts). Most patients are able to return to work the next day due to quick recovery utilizing the IntraLase flap technology.
Who is a candidate for iLASIK?
Eligible candidates must be 18 years of age, have a stable prescription and have proper corneal shape and tissue to allow for treatment. 94% of patients qualify based on their prescription alone, with the CustomVue laser technology which has the largest FDA approved range available. However, other factors may cause iLASIK not to be recommended, such as uncontrolled systemic diseases like diabetes or rheumatoid arthritis. A thorough examination is the best way to determine if you are a candidate for iLASIK.
To learn more about iLASIK click here.